Wave life sciences to present at 2024 jefferies global healthcare conference

Cambridge, mass., may 30, 2024 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage biotechnology company focused on unlocking the broad potential of rna medicines to transform human health, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to present at the 2024 jefferies global healthcare conference in new york city on thursday, june 6, 2024, at 7:30 a.m. et.
WVE Ratings Summary
WVE Quant Ranking